| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.076 | 0.2 |